Psychiatry and Neurology, Neurology · Philadelphia, PA
NPI
1801816681
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
900 Walnut St, 2nd Floor
Philadelphia, PA, 19107
Phone (215) 955-6871
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
843 services
Medicare patients, 2024
284
Average age 62
Drug cost, 2024
$3.5M
2,075 prescriptions
Company payments, 2025
$124K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas P Leist was code 99215 (office e&m - established), 239 times for 138 patients. In total Thomas P Leist billed 843 services in 24 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 239 | 138 | $102.39 | $24K |
| 99213 Office E&M - Established | Facility | 189 | 70 | $48.58 | $9,182 |
| 99214 Office E&M - Established | Facility | 77 | 52 | $69.82 | $5,376 |
| 99310 SNF E&M | Facility | 46 | 29 | $123.72 | $5,691 |
| 99309 SNF E&M | Facility | 44 | 27 | $85.07 | $3,743 |
| 99214 Office E&M - Established | Office | 35 | 33 | $81.99 | $2,870 |
| 99215 Office E&M - Established | Office | 20 | 15 | $100.90 | $2,018 |
| 95874 Musculoskeletal | Facility | 20 | 17 | $41.14 | $823 |
| 64644 Musculoskeletal | Facility | 18 | 13 | $95.38 | $1,717 |
| 99205 Office E&M - New | Facility | 11 | 11 | $133.03 | $1,463 |
By year: 2022 $55K for 649 services; 2023 $63K for 757 services; 2024 $64K for 843 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas P Leist prescribed most often to Medicare patients was Baclofen, with 244 prescriptions and refills. In total Thomas P Leist wrote 2,075 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 244 | 601 | 90 | $8,342 |
| Gabapentin Generic | 188 | 384 | 65 | $3,991 |
| Dalfampridine Er Dalfampridine | 144 | 220 | 34 | $97K |
| Teriflunomide Generic | 122 | 156 | 22 | $321K |
| Tizanidine Hcl Generic | 118 | 288 | 54 | $4,726 |
| Kesimpta Pen Ofatumumab | 97 | 99 | 18 | $901K |
| Duloxetine Hcl Generic | 82 | 202 | 29 | $3,244 |
| Glatiramer Acetate Generic | 63 | 76 | 13 | $179K |
| Modafinil Generic | 58 | 132 | 24 | $3,779 |
| Celecoxib Generic | 56 | 78 | 18 | $2,892 |
| Aubagio Teriflunomide | 53 | 53 | Under 11 | $492K |
| Diazepam Generic | 52 | 69 | 13 | $203 |
| Dimethyl Fumarate Generic | 38 | 44 | Under 11 | $62K |
| Copaxone Glatiramer Acetate | 38 | 45 | Under 11 | $267K |
| Amantadine Amantadine Hcl | 37 | 77 | 14 | $1,728 |
Brand drugs: 343 claims; generic drugs: 1,732 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas P Leist $124K ($124K in general payments such as food, travel and fees) from 16 companies. The largest payer was TG Therapeutics, Inc. with $39K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 36 | $39K |
| Amgen Inc. AMGN | 37 | $27K |
| Genentech USA, Inc. ROG.SW | 14 | $18K |
| Alexion Pharmaceuticals, Inc. AZN | 12 | $15K |
| Biogen, Inc. BIIB | 20 | $11K |
| Novartis Pharmaceuticals Corporation NVS | 14 | $7,884 |
| Genzyme Corporation SNY | 5 | $5,719 |
| EMD Serono, Inc. MRK.DE | 12 | $350 |
| Celgene Corporation BMY | 11 | $159 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $114 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.